RxDoctor Payments Data

Terry Vik

Pediatric Hematology-Oncology · Indianapolis, INNPI 1861585762

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,480 of the $2,575 with a category attached, or 96.3%. Every reported general payment came from a single manufacturer, Beckman Coulter, Inc..

$2,575in general payments, 2019–2025

Across 3 payments — averaging $858.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Beckman Coulter, Inc.$3K
$1,792,395in research payments, 2019–2025

Across 6 payments — averaging $298,732 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$1.8M
  • Y-mabs Therapeutics, Inc.$42K

What the payments were for

  • Speaking & faculty fees$2,48096%
  • Food & beverage$954%

General payments by program year

22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Beckman Coulter, Inc.3$2,575

How this compares

$2,575 in reported general payments places this provider in the 75th percentile of 59 pediatric hematology-oncology providers in Indiana.

See all pediatric hematology-oncology providers in Indiana

Other pediatric hematology-oncology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →